ITMI912070A1 - USE - Google Patents

USE

Info

Publication number
ITMI912070A1
ITMI912070A1 IT91MI002070A ITMI912070A ITMI912070A1 IT MI912070 A1 ITMI912070 A1 IT MI912070A1 IT 91MI002070 A IT91MI002070 A IT 91MI002070A IT MI912070 A ITMI912070 A IT MI912070A IT MI912070 A1 ITMI912070 A1 IT MI912070A1
Authority
IT
Italy
Prior art keywords
pct
zambeletti
coughs
convulsions
pancreatitis
Prior art date
Application number
IT91MI002070A
Other languages
Italian (it)
Inventor
Giuseppe Giardina
Roberto Colle
Clarke Geoffrey Douglas
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Priority to IT91MI002070A priority Critical patent/ITMI912070A1/en
Publication of ITMI912070A0 publication Critical patent/ITMI912070A0/en
Publication of ITMI912070A1 publication Critical patent/ITMI912070A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso dei composti descritti in EP-A-228246, 232612, 232989, 260041, 261842, 275696, 330360, 333315, 333427, 361791, 370732, 409489, WO91/08205, WO91/08206, PCT/EP91/00717 e PCT/EP91/00931 (tutte a nome Dr. L. Zambeletti S.p.A.) e loro sali o solvati farmaceuticamenteaccettabili, per la fabbricazione di medicamenti atti al trattamento e/o alla profilassi di convulsioni, tosse, asma, infiammazione o pancreatite; e relative composizioni farmaceutiche.Use of the compounds described in EP-A-228246, 232612, 232989, 260041, 261842, 275696, 330360, 333315, 333427, 361791, 370732, 409489, WO91 / 08205, WO91 / 08206, PCT / EP91 / 00717 and PCT / EP91 / 00931 (all in the name of Dr. L. Zambeletti SpA) and their pharmaceutically acceptable salts or solvates, for the manufacture of medicaments suitable for the treatment and / or prophylaxis of convulsions, coughs, asthma, inflammation or pancreatitis; and related pharmaceutical compositions.

IT91MI002070A 1991-07-26 1991-07-26 USE ITMI912070A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT91MI002070A ITMI912070A1 (en) 1991-07-26 1991-07-26 USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT91MI002070A ITMI912070A1 (en) 1991-07-26 1991-07-26 USE

Publications (2)

Publication Number Publication Date
ITMI912070A0 ITMI912070A0 (en) 1991-07-26
ITMI912070A1 true ITMI912070A1 (en) 1993-01-26

Family

ID=11360431

Family Applications (1)

Application Number Title Priority Date Filing Date
IT91MI002070A ITMI912070A1 (en) 1991-07-26 1991-07-26 USE

Country Status (1)

Country Link
IT (1) ITMI912070A1 (en)

Also Published As

Publication number Publication date
ITMI912070A0 (en) 1991-07-26

Similar Documents

Publication Publication Date Title
ITFI930247A1 (en) ANTAGONISTS OF TACHYCININS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
ES8706169A1 (en) Peptide derivatives.
MX9702380A (en) New carboxamides with antifungal activity.
ES554967A0 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL FORMULATION CONTAINING A 2'3'-DIDESOXI-NUCLEOSIDE.
MX9702382A (en) New pyrimidone derivatives with antifungal activity.
SE9604786D0 (en) New compounds
CA2098302A1 (en) Medicaments
DE69738000D1 (en) New pharmaceutical formulation containing budesonide
PT804252E (en) METALLIC CHELTER AGENTS THAT CONTAINS DIAMOND MONOAMINES AND THIOIS
TR200302214T4 (en) Pteridine compounds used for the treatment of psoriasis
CA2284551A1 (en) New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
ES2163425T3 (en) USE OF RALOXIFENO AND ITS ANALOGS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS AND ISCHEMICAL CARDIAC DISEASE.
NO924066D0 (en) THERAPEUTIC AGENT
ES2154669T3 (en) USE OF 2-PHENYL-3-AROILBENZOTIOPHENES FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE INHIBITION OF THE DEGRADATION OF CARTILAGO.
IT1229477B (en) USE OF 5 'DEOXY - 5' METHYLTHIOADENOSINE, S ADENOSYLMETHIONINE AND THEIR SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS TO REDUCE SEBORRHEA AND RELATED PHARMACEUTICAL COMPOSITIONS
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
IT1276162B1 (en) GERANYLGERANIL DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
IT1256623B (en) TACHYCHININ ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS
IT8948430A0 (en) TRIPEPTIDE COMPOUNDS AND THEIR PHARMACEUTICAL USE AS IMMUNO-MODULATORS
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
ITMI912070A1 (en) USE
AU3809789A (en) 9-(2-valeryloxyethoxymethyl) guanine and pharmacologically acceptable salts thereof
IT9019793A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
IT1255461B (en) ETHERS OF IMIDAZOLI ACTIVATED IN II ANTAGONIST

Legal Events

Date Code Title Description
0002 Rejected